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ABSTRAK
Tujuan: untuk mengetahui efek bayi berat lahir rendah (BBLR) terhadap fungsi endotel dan menentukan 
peran adiponektin plasma pada disfungsi endotel melalui pemeriksaan flow mediated brachial artery (FMBA) 
atau respon vasodilatasi (VR) dan mengukur kadar asymmetrical dimethylarginine (ADMA) plasma subjek 
dewasa muda dengan riwayat BBLR. Metode: pada penelitian kohort retrospektif, subjek diambil secara acak 
dari suatu growth study cohort Kecamatan Tanjungsari Kabupaten Sumedang Jawa Barat. Mereka terdiri atas 
67 subjek dengan riwayat BBLR dan 67 subjek dengan riwayat bayi berat lahir normal (BBLN). Variabel terikat 
adalah kadar adiponektin plasma, ADMA plasma dan nilai VR. Uji yang digunakan untuk mengetahui korelasi 
antara adiponektin plasma dan ADMA adalah korelasi Pearson. Hasil: kelompok BBLR secara bermakna 
mempunyai VR yang lebih rendah, RR=2,94 dengan 95% CI=1,91-4,53; dan kadar adiponektin plasma rendah 
RR =1,53 dengan 95% CI =1,07-2,18. Seluruh variabel (plasma adiponektin, plasma ADMA dan nilai VR) 
antara kelompok BBLR dan BBLN menunjukkan perbedaan bermakna pada 2 variabel yaitu nilai VR (p<0,001, 
95% CI= -4,409-(-2,114) dan kadar adiponektin plasma yang lebih rendah (p=0,015, 95% CI= -1,083-(-0,082) 
pada kelompok BBLR dibandingkan kelompok BBLN. Tidak ada korelasi antara kadar adiponektin plasma 
dan kadar ADMA plasma, maupun antara kadar adiponektin plasma dan nilai VR. Kesimpulan: BBLR berefek 
pada fungsi endotel. BBLR dibandingkan dengan BBLN memiliki nilai VR dan adiponektin plasma yang lebih 
rendah. Adiponektin plasma berperan kecil pada disfungsi endotel subjek dewasa muda dengan riwayat BBLR.
Kata kunci: BBLR, adiponektin, ADMA, pemeriksaan FMBA.
ABSTRACT
Aim: to investigate the effect of low birth weight (LBW) on endothelial function, and to determine the role 
of plasma adiponectin in endothelial dysfunction by conducting flow mediated brachial artery (FMBA) test 
or vasodilation response (VR) and by measuring plasma asymmetrical dimethylarginine (ADMA) of young 
adults born with LBW. Methods: in a retrospective cohort study, subjects were randomly selected from the 
growth study cohort of Tanjungsari Sumedang district West Java. They consisted of 67 LBW and 67 NBW 
(Normal Birth Weight) young adults. Dependent variables were plasma adiponectin, plasma ADMA, and VR. 
The correlation between plasma adiponectin and ADMA level was examined using Pearson’s correlation. 
Results: the relative risk for LBW to have low brachialis artery vasodilation response was 2.94, (95% CI:1.91-
4.53), and to have low of plasma adiponectin concentration 1.53, (95% CI: 1.07-2.18). There was a statistically 
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INTRODUCTION
Low birth weight (LBW) may increase the 
risk of cardiovascular diseases during adulthood. 
Intrauterine growth restriction can lead to 
alteration of organ, function, and metabolism 
and also to persistent endocrine disorders.1 
Adiponectin is a protein that is synthesized 
by fat cells, and play an important role in 
fetal growth.2,3 In LBW, the low adiponectin 
concentration persists through the childhood 
and adulthood.4,5 Apart from insulin sensitizer 
effect, adiponectin has also antithrombotic and 
antisclerotic properties, that directly influence 
the endothelial function.6
Endothelial dysfunction is a foundation for 
atherosclerosis. One of the endothelial functions 
which will first be disturbed is vasodilation 
and vasoconstriction balance. Nitric oxide 
(NO) is one of vasodilators produced by the 
endothelial cells, which has a very short half-
time of 3-5 seconds, and can be clinically 
detected as a vasodilatation response (VR) on 
the flow mediated brachial artery (FMBA) test7-
9 Asymmetric dimethylarginine (ADMA) is a 
laboratory marker of endothelial dysfunction that 
acts as an endogen inhibitor of endothel nitric 
oxide synthase (eNOS) an enzyme that competes 
with arginine, which is a NO precursor.10
LBW incidence in Indonesia is still 
high of about 11.5%.11 Therefore, the aim of 
this study is to define the effect of LBW on 
endothelial function represented by VR value 
and plasma ADMA level; and to determine the 
role of adiponectin on endothelial dysfunction 
represented by ADMA level.
METHODS
This was a clinical epidemiological study 
conducted in a retrospective fashion, from 
November 2009 until January 2010. Subjects 
were obtained from the growth study cohort of 
Tanjungsari, Sumedang District, West Java12 
who fulfilled the inclusion criteria (Figure 1). 
LBW
Subjects who fulfill
SIMPLE  RANDOM
NBW
NBW
LBW NBW
Subjects who participated in the study
LBW NBW
LBW
n = 67 n = 67
Figure 1. Subjects obtained from the growth study cohort of 
Tanjungsari, Sumedang District, West Java
significant difference for all variables studied (FMBA, plasma ADMA, and plasma Adiponectin concentrations), 
while simultaneous confidence interval measurements indicated that the value of FMBA and the concentration of 
plasma adiponectin were significantly lower, respectively p<0.001, 95% CI: -4.409-(-2.114), and p=0.015, 95% 
CI: -1.083-(-0.082) in LBW compared to NBW subjects. The correlation between plasma adiponectin concentration 
and plasma ADMA concentration in LBW subjects was not significant. Conclusion: there is an effect of LBW on 
endothelial function. LBW compared to NBW subjects have lower VR and plasma adiponectin concentration. There 
may be a small role of plasma adiponectin in endothelial dysfunction of young adults with LBW.
Key words: low birth weight, adiponectin, ADMA, FMBA test.
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LBW as a risk compared with control group 
born with NBW, which had been identified from 
19 to 21 years ago. The outcome were plasma 
adiponectin, plasma ADMA, and brachial artery 
VR.
Inclusion criteria included the following: 
males or females, ranging in age from 19 until 
21 years old, had birth weight and length data, 
had taken part in previous risk factor study, and 
had been previously randomized. Patients were 
exluded if one of the following occurred: i) 
chronic renal failure, ii) liver disease, iii) heart 
failure, iv) antidiabetic drug, nitrate drug, steroid 
drug and multivitamin consumption.
In this study, chronic renal failure was defined 
as chronic kidney disease stages 3,4 and 5 with 
glomerular filtration rate (GFR) <59, <29 and 
<15 mL/minute per 1.73 m2.13 Liver disease was 
defined as liver cell injury with the elevation of 
alanine aminotransferase (ALT) >1000 U/L, of 
at least 300 U/L.14 Epidemiology criteria of the 
Framingham Study was used to consider heart 
failure which met two majors or one major criteria 
plus two minors criteria.15
Ultrasonography General Electric logic was 
used to obtain the diameter of brachial artery. 
Diameter of brachial artery was measured before 
and within the first minute after occlusion. VR 
value (in %) is the differences of diameter of 
brachial artery after and before occlusion.9,16
Human adiponectin operates based on the 
underlying principle of a sandwich enzyme-
linked immunosorbent assay (ELISA) that 
uses two kinds of anti-human adiponectin 
monoclonal antibodies (MoAbs). The specimens 
are pretreated, total adiponectin and individual 
multimers of adiponectin are determined 
selectively, directly or indirectly. Reference 
value: male 2.54-6.06 μg/mL, female 3.58-9.66 
μg/mL. Determine the absorbance of each well 
at a wavelength of 492 nm with a plate reader. 
Reference value: male 2.54-6.06 μg/mL, female 
3.58-9.66 μg/mL.
 The competitive ADMA-ELISA uses the 
microtiter plate format. ADMA is bound to the 
solid phase of the microtiter plate. ADMA in 
the samples is acylated and competes with solid 
phase bound ADMA for a fixed number of rabbit 
anti-ADMA antiserum binding sites. When the 
system is in equilibrium, free antigen and free 
antigen-antiserum complexes are removed by 
washing. The antibody bound to the solid phase 
ADMA is detected by anti-rabbit/peroxidase. 
The substrate/peroxidase reaction is monitored 
at 450 nm. The amount of antibody bound to the 
solid phase ADMA is inversely proportional to 
the ADMA concentration of the sample (expected 
values: 0.4-0.75 µmol/L).
This study approved by The Health Research 
Ethics Committee of Dr. Hasan Sadikin General 
Hospital-Faculty of Medicine Universitas 
Padjadjaran, Bandung.
Statistical Analysis
The cut-off points were low plasma 
adiponectin concentration, high plasma ADMA 
concentration, and low brachialis artery VR value 
which were determined by diagnostic testing 
using the receiver operating characteristics 
(ROC) curves.
Normality testing of data distribution was 
conducted before completing the statistical 
analysis using the Lilliefors significance 
correction. The correlation between plasma 
adiponectin and ADMA level was examined 
using Pearson’s correlation if the data had normal 
distribution. The subject characteristic data were 
stated in mean value and standard deviation (SD). 
All statistical analysis were conducted using 
the SPSS window software version 13.0. The 
values of p<0.05 were considered statistically 
significant.
RESULTS
There were 67 LBW subjects and 67 NBW 
subjects enrolled in this study. None of the 
patients in each group received anti diabetic, 
antihypertensive, nitrate, vasoactive drugs and/or 
multivitamin. The general characteristics of two 
groups were not significantly different (Table 1).
The Associat ion between LBW and 
Concentrations of VR, Plasma Adiponectin, 
and Plasma ADMA
Cut-off point for low plasma adiponectin 
concentration from the receiving operating 
characteristic (ROC) curve is <4.13 ug/ml 
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and low VR value is <9.5%, while for high 
plasma ADMA concentration is >0.89 mMol/L. 
Significantly, the LBW groups are prone to have 
low VR and low plasma adiponectin than NBW 
group (Table 2).
The Mean Plasma Adiponectin Concentration, 
Plasma ADMA Concentration and VR 
Differences in Young Adults Born with LBW 
and NBW
All three variables showed very significant 
differences according to the statistical testing 
using t-test for two independent samples. The 
next statistical testing using the simultaneous 
confidence interval found significantly 
different mean variables of plasma adiponectin 
concentration and VR value between LBW and 
NBW. The baseline distribution of Brachialis 
artery diameter in both groups was not 
significantly different, but VR value showed 
significant difference between both groups. The 
mean plasma ADMA concentration of LBW was 
not significantly different (p= 0.669) compared 
with the NBW group. (Table 3)
Table 2. Relative risk for LBW to have low VR, low plasma adiponectin concentration, and high plasma ADMA concentration 
(n=67)
Variables
Adiponectin  
(mg/ml) p RR  (95%CI)
VR (%)
p RR  (95%CI)
ADMA (mMol/L)
p RR (95%CI)
<4.13 >4.13 <9.5 >9.5 >0.89 <0.89
LBW
41 
(60.3%)
26 
(39.4%)
0.016
1.53 
(1.07-2.18)
50 
(74.6)
17 
(25.4)
<0.001
2.94
(1.91-4.53)
12 
(63.2%)
55 
(47.8%)
0.216
1.32 
(0.89-1.96)
NBW
27 
(39.7%)
40 
(60.6%)
17 
(25.4)
50 
(74.6)
7 
(36.8%)
60 
(52.2%)
Note: Chi square test, VR = vasodilation response,  RR = relative risk for LBW
Table 3. The mean plasma adiponectin concentration, plasma ADMA concentration, and brachialis artery VR differences 
between young adults born with LBW and NBW
Variables LBW (n=67) NBW (n=67) p 95% CI for difference
Plasma Adiponectin, 
μg/ml
4.07 (1.29) 4.64 (1.61) 0.015* -1.083-(-0.082)*
Brachialis Artery VR, 
% 8.40 (3.06) 11.66 (3.63) <0.001* -4.409-(-2.114)*
Baseline diameter of 
Brachialis Artery, Cm 3.35 (0.47) 3.33 (0.42) 0.758**
Plasma ADMA, μMol/L 0.71 (0.15) 0.69 (0.15) 0.669* -0.041-(0.064)*
* Simultaneous confidence interval, ** Independent t-test
Table 1. General characteristics of young adults born with 
LBW and NBW
Parameters LBW (n=67) NBW (n=67)
Age, years old 20.3 (0.5) 20.2 (0.58)
Male, % 52.2 56.7
SBP, mmHg 117 (10) 119 (10)
DBP, mmHg 76 (6) 78 (7)
Hemoglobin, gr% 15.0 (1.6) 15.3(1.3)
Fasting blood glucose, 
mg/dL
86.0 (6.7) 84.8 (8.7) 
Total cholesterol, mg/dL 158.5 (26.7) 161.3 (30.1)
Trigliserid, mg/dL 84.4 (40.4) 95.10(51.4)
HDL-C, mg/dL 44.4 (8.8) 43.5 (8.5)
LDL-C, mg/dL 100.1 (23.6) 101.8( 24.6) 
SGOT, unit/litre 21.6 (6.5) 21.5 (7.0)
SGPT, unit/litre 21.5 (13.6)  20.4 (10.9)
Blood urea, mg/dL 19.1 (5.4) 18.3 (4.5)
Creatinine, mg/dL 0.68 (0.14) 0.71 (0.16)
Smoker: male, % 88.6 89.5 
BMI, kg/M2 20.1 (3.3) 20.7 (3.2)
Diabetes Mellitus None None
Hypertension (BP 
>140/90 mmHg), n 1 3
BMI=body mass index, SBP=systolic blood pressure, 
DBP=diastolic blood pressure
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Correlation Between Plasma Adiponectin, 
and Plasma ADMA, and Brachialis Artery VR 
in Young Adult Subject Born with LBW
There were no correlation between plasma 
adiponectin and plasma ADMA (R= -0.16, 
p=0.176), and between plasma adiponectin and 
VR (R=0.13, p=0.281) in LBW. Significant 
correlation was found between baseline diameter 
of Brachial artery and VR (R=0.27, p=0.028), 
with smaller Brachial artery diameter associated 
with bigger VR. 
DISCUSSION
Main finding of this study was that VR 
significantly differ between LBW and NBW 
groups, although the baseline diameter of 
Brachialis artery in both groups were similar.
The endothelial dysfunction was clinically 
found more in the young adult group born with 
LBW compared with NBW that appeared as low 
VR (8.4% vs 11.6%) on FMBA test. Leeson et 
al found that low VR in LBW was a result of 
vascular function alteration relating to in-utero 
growth disturbance.16
Poor nutrition during fetal growth will 
result in the alteration of the organ structure and 
function, also in the metabolism disturbance that 
appear as LBW with low plasma adiponectin 
concentration. Adiponectin raises the NO 
production through eNOS enzyme stimulation. 
Plasma adiponectin concentration in this study 
was significantly lower in LBW compared with 
NBW group. This is similar to the result of 
study by Kamoda et al (2001)4 and Cianfarani 
et al (2004).5 Unlike our study, they compared 
the Small for Gestational Age group (birth 
weight=2.1 + 0.4 kg) and Appropriate for 
Gestational Age group (birth weight=3.0+0.8 
kg). In this study, both groups (LBW and 
NBW) had same BMI (about 20 kg/M2). We 
could not eliminate the low plasma adiponectin 
concentration in LBW as the result of fatty 
tissue malfunction according to Barker & Hales’ 
study1 and as a result of genetic factor like single 
nucleotid polymorphysms 276 on Adiponectin 
gene,6 therefore further studies are needed.
In this study, no significant correlation 
between plasma adiponectin and VR, as well 
as plasma adiponectin and plasma ADMA were 
found. Adiponectin might have some effect on 
endothelial dysfunction of young adults with 
LBW.
Other factors might have influenced the final 
results which precludes us from drawing definite 
conclusions, before thorough evaluation.
There are a variety of vascular or 
endothelial functions, however vasodilation and 
vasoconstriction balance is affected earliest.17 
In addition to the NO vasodilator synthesis 
disturbance, the potential role of excessive 
vasoconstrictors in LBW subjects such as 
endothelin-1, angiotensin II, thromboxan A2, and 
prostagladine H2 deserve further investigation.
The mean plasma ADMA concentration of 
LBW was not significantly different compared 
with the NBW. Only few studies have examined 
the protein arginine N-methyltransferase 
(PRMT) activity regulation. The study by Osanai 
et al (2003)18 found that ADMA concentrations 
were influenced by shear stress. In physiologic 
state, shear stress increases the PRMT-1 
expression and ADMA synthesis through NF-
kB path activation. However, in the presence of 
shear stress, the dimethylarginine dimethylamin 
hydrolase-II (DDAH-II) activity would also 
increase resulting in ADMA degradation. In this 
study, the blood samples for ADMA examination 
were obtained before conducting of FMBA 
test, thus preventing any differences between 
the two groups. Oxidative stress that results in 
ADMA accumulation19 could be eliminated if 
only the general characteristics of both groups 
were similar eg. smoking, systolic and diastolic 
blood pressure, blood glucose concentration, 
and blood fat concentration between LBW and 
NBW groups.
One factor that could influence plasma 
Adiponectin and ADMA is TNFa. Tumor necrosis 
factor a inhibits the Adiponectin production,20-22 
but induces the ADMA accumulation.23 The 
possibility of fatty tissue function disturbance1, 
especially in TNFa synthesis which is strictly 
related to adiponectin production and ADMA 
accumulation, cannot be ruled out.
The low plasma adiponectin concentration 
and endothelial dysfunction condition persist 
through the childhood and into adulthood 
periods. A nonsignificant correlation between 
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plasma adiponectin and either plasma ADMA 
concentration, and VR revealed no potential 
role of adiponectin in endothelial dysfunction 
in LBW. There might be other factors in cellular 
level that influence the endothelial function.
Finally, beyond small sample size, other 
potential limitation are the involvement of 
intrauterine growth retardation (IUGR), and 
preterm subjects in LBW group. The findings of 
this report therefore need further confirmation in 
future studies with adequately powered.
CONCLUSION
Low birth weight modulates endothelial 
function. LBW compared to NBW subjects have 
lower VR and plasma adiponectin concentration. 
There may be a small role of plasma adiponectin 
in endothelial dysfunction of young adults with 
LBW; however other variables might have 
important role and further studies are needed 
before definite conclusions regarding plasma 
adiponectin could be drawn.
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